home / stock / cbay / cbay quote
Last: | $32.48 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $32.48 |
High: | $0 |
Low: | $0 |
Volume: | 73 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$32.48 | $0 | $32.48 | $0 | $0 | 73 | 04-01-2024 |
$32.48 | $32.49 | $32.48 | $32.5 | $32.48 | 8,356,254 | 03-21-2024 |
$32.47 | $32.49 | $32.47 | $32.49 | $32.47 | 1,518,195 | 03-20-2024 |
$32.48 | $32.47 | $32.48 | $32.48 | $32.46 | 2,367,068 | 03-19-2024 |
$32.46 | $32.46 | $32.46 | $32.48 | $32.45 | 3,468,071 | 03-18-2024 |
$32.45 | $32.45 | $32.45 | $32.47 | $32.44 | 2,824,445 | 03-15-2024 |
$32.47 | $32.44 | $32.47 | $32.47 | $32.42 | 2,694,701 | 03-14-2024 |
$32.44 | $32.44 | $32.44 | $32.46 | $32.43 | 4,144,245 | 03-13-2024 |
$32.44 | $32.43 | $32.44 | $32.46 | $32.43 | 3,663,312 | 03-12-2024 |
$32.44 | $32.43 | $32.44 | $32.465 | $32.42 | 6,108,202 | 03-11-2024 |
$32.31 | $32.3 | $32.31 | $32.33 | $32.28 | 1,771,003 | 03-08-2024 |
$32.3 | $32.28 | $32.3 | $32.3 | $32.27 | 1,167,448 | 03-07-2024 |
$32.29 | $32.25 | $32.29 | $32.3 | $32.25 | 1,396,148 | 03-06-2024 |
$32.24 | $32.21 | $32.24 | $32.27 | $32.19 | 2,279,199 | 03-05-2024 |
$32.18 | $32.24 | $32.18 | $32.3 | $32.16 | 2,154,189 | 03-04-2024 |
$32.23 | $32.23 | $32.23 | $32.35 | $32.19 | 3,498,446 | 03-01-2024 |
$32.19 | $32.28 | $32.19 | $32.3 | $32.17 | 7,914,335 | 02-29-2024 |
$32.27 | $32.32 | $32.27 | $32.33 | $32.26 | 3,487,162 | 02-28-2024 |
$32.32 | $32.26 | $32.32 | $32.33 | $32.24 | 2,840,323 | 02-27-2024 |
$32.28 | $32.23 | $32.28 | $32.31 | $32.21 | 3,262,076 | 02-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
CymaBay Therapeutics Inc. Company Name:
CBAY Stock Symbol:
NASDAQ Market:
100.0% G/L:
$32.48 Last:
73 Volume:
$0 Open:
$32.48 Close:
CymaBay Therapeutics Inc. Website:
Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver Diseases Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for appr...
CymaBay Therapeutics, Inc. (NASDAQ: CBAY) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.06% on the day to $32.49. CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chr...
2024-03-12 10:45:01 ET UiPath Inc (PATH) PATH is trading UP for the last 5 days, and it at trading at $24.64 with volume of 4,269,666 and a one day change of $0.54 (2.25%). UiPath Inc has a 52-week low of 12.38 and a 52-week high of $27.87. The business's 50-day moving average price...